Cosciens Biopharma Signs Exclusive Macrilen Distribution Deal with Wuzhou Drug International
I'm PortAI, I can summarize articles.
Cosciens Biopharma's subsidiary, Aeterna Zentaris GmbH, signed an exclusive distribution agreement with Wuzhou Drug International for Macrilen® in Hong Kong, Macao, Singapore, and parts of China. Wuzhou will manage registration, importation, and commercialization, with a ten-year term and an initial order of €800,000. The news was published by Cosciens Biopharma via GlobeNewswire.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments